Brief: Anaptys Announces Second Quarter And Transitional Fiscal Year 2026 Financial Results And Provides Business Update
21/09/2026 23:10
BRIEF-Anaptys Announces Second Quarter And Transitional Fiscal Year 2026 Financial Results And Provides Business Update Sept 22 (Reuters) - AnaptysBio, Inc. ANAB.O:
ANAPTYS ANNOUNCES SECOND QUARTER AND TRANSITIONAL FISCAL YEAR 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Source text: ID:nGNXbdmb8S
Further company coverage: ANAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AnaptysBio
See all newsFirst Tracks Biotherapeutics up after $200 mln equity raise
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Brief: Anaptys Announces Second Quarter And Transitional Fiscal Year 2026 Financial Results And Provides Business Update
AnaptysBio Q2 collaboration revenue rises on higher Jemperli royalties